Back to Search
MARK MASS, MD
MD
Urgent Care Clinic/Center
NPI: 1841276847IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medical Services (Emergency Medicine) Physician
Emergency Medicine — Emergency Medical Services
Code: 207PE0004X
36093222(IL)
Urgent Care Clinic/CenterPrimary
Clinic/Center — Urgent Care
Code: 261QU0200X
036-093222(IL)
Occupational Medicine Physician
Preventive Medicine — Occupational Medicine
Code: 2083X0100X
036-093222(IL)
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
036-093222(IL)
Occupational Medicine Clinic/Center
Clinic/Center — Occupational Medicine
Code: 261QX0100X
036-093222(IL)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1988
Research & Publications (20)
Child protection and the conception of parental responsibility.
PMID 15839759·Am J Orthopsychiatry·2005
8-other
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.
PMID 17944900·Immunology·2008
3-trial
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
PMID 16436649·Neurology·2006
2-rct
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
PMID 15781814·Neurology·2005
3-trial
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
PMID 16193893·Mult Scler·2005
3-trial
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients.
PMID 16323317·Mult Scler·2005
3-trial
Eight-year immunogenicity and safety of interferon beta-1a-Avonex treatment in patients with multiple sclerosis.
PMID 16042223·Mult Scler·2005
3-trial
Randomized controlled trial of yoga and exercise in multiple sclerosis.
PMID 15184614·Neurology·2004
3-trial
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.
PMID 12617260·Mult Scler·2003
3-trial
Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations.
PMID 14556226·Environ Mol Mutagen·2003
8-other
Erythroid pyrimidine 5'-nucleotidase: cloning, developmental expression, and regulation by cAMP and in vivo hypoxia.
PMID 12907448·Blood·2003
7-preclinical
K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China.
PMID 12826308·Lung Cancer·2003
8-other
Induction of genotoxic damage is not correlated with the ability to methylate arsenite in vitro in the leukocytes of four mammalian species.
PMID 12112384·Environ Mol Mutagen·2002
7-preclinical
The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells.
PMID 11751853·J Biol Chem·2002
8-other
DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species.
PMID 12482246·Chem Res Toxicol·2002
8-other
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.
PMID 11376182·Neurology·2001
8-other
Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene.
PMID 11592112·J Neurosci Res·2001
4-observational
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
PMID 11902591·Neurology·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1025 W EVERETT RD, SUITE 101
LAKE FOREST, IL 60045 - Phone
- (847) 234-7950
Quick Facts
- NPI
- 1841276847
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile